Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.